ID   CADH3_HUMAN             Reviewed;         829 AA.
AC   P22223; B2R6F4; Q05DI6;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   22-JUL-2015, entry version 156.
DE   RecName: Full=Cadherin-3;
DE   AltName: Full=Placental cadherin;
DE            Short=P-cadherin;
DE   Flags: Precursor;
GN   Name=CDH3; Synonyms=CDHP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT HIS-563.
RX   PubMed=2793940; DOI=10.1083/jcb.109.4.1787;
RA   Shimoyama Y., Yoshida T., Terada M., Shimosato Y., Abe O.,
RA   Hirohashi S.;
RT   "Molecular cloning of a human Ca2+-dependent cell-cell adhesion
RT   molecule homologous to mouse placental cadherin: its low expression in
RT   human placental tissues.";
RL   J. Cell Biol. 109:1787-1794(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   HIS-563.
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT HIS-563.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   MET-237.
RC   TISSUE=Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-15.
RC   TISSUE=Fetal brain;
RX   PubMed=9815605;
RA   Jarrard D.F., Paul R., Van Bokhoven A., Nguyen S.H., Bova G.S.,
RA   Wheelock M.J., Johnson K.R., Schalken J., Bussemakers M., Isaacs W.B.;
RT   "P-cadherin is a basal cell-specific epithelial marker that is not
RT   expressed in prostate cancer.";
RL   Clin. Cancer Res. 3:2121-2128(1997).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=2702654;
RA   Shimoyama Y., Hirohashi S., Hirano S., Noguchi M., Shimosato Y.,
RA   Takeichi M., Abe O.;
RT   "Cadherin cell-adhesion molecules in human epithelial tissues and
RT   carcinomas.";
RL   Cancer Res. 49:2128-2133(1989).
RN   [7]
RP   INTERACTION WITH CDCP1.
RX   PubMed=16007225; DOI=10.1038/sj.onc.1208582;
RA   Bhatt A.S., Erdjument-Bromage H., Tempst P., Craik C.S., Moasser M.M.;
RT   "Adhesion signaling by a novel mitotic substrate of src kinases.";
RL   Oncogene 24:5333-5343(2005).
RN   [8]
RP   INVOLVEMENT IN HJMD.
RX   PubMed=11544476; DOI=10.1038/ng716;
RA   Sprecher E., Bergman R., Richard G., Lurie R., Shalev S.,
RA   Petronius D., Shalata A., Anbinder Y., Leibu R., Perlman I., Cohen N.,
RA   Szargel R.;
RT   "Hypotrichosis with juvenile macular dystrophy is caused by a mutation
RT   in CDH3, encoding P-cadherin.";
RL   Nat. Genet. 29:134-136(2001).
RN   [9]
RP   INTERACTION WITH CTNNB1.
RX   PubMed=17052462; DOI=10.1016/j.molcel.2006.09.001;
RA   Sampietro J., Dahlberg C.L., Cho U.S., Hinds T.R., Kimelman D., Xu W.;
RT   "Crystal structure of a beta-catenin/BCL9/Tcf4 complex.";
RL   Mol. Cell 24:293-300(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   VARIANT HJMD HIS-503.
RX   PubMed=12445216; DOI=10.1046/j.1523-1747.2002.19528.x;
RA   Indelman M., Bergman R., Lurie R., Richard G., Miller B.,
RA   Petronius D., Ciubutaro D., Leibu R., Sprecher E.;
RT   "A missense mutation in CDH3, encoding P-cadherin, causes
RT   hypotrichosis with juvenile macular dystrophy.";
RL   J. Invest. Dermatol. 119:1210-1213(2002).
RN   [12]
RP   VARIANT EEMS ILE-322, AND VARIANT HIS-563.
RX   PubMed=15805154; DOI=10.1136/jmg.2004.027821;
RA   Kjaer K.W., Hansen L., Schwabe G.C., Marques-de-Faria A.P., Eiberg H.,
RA   Mundlos S., Tommerup N., Rosenberg T.;
RT   "Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly,
RT   macular dystrophy (EEM syndrome).";
RL   J. Med. Genet. 42:292-298(2005).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       They preferentially interact with themselves in a homophilic
CC       manner in connecting cells; cadherins may thus contribute to the
CC       sorting of heterogeneous cell types.
CC   -!- SUBUNIT: Interacts with CDCP1 and CTNNB1.
CC       {ECO:0000269|PubMed:16007225, ECO:0000269|PubMed:17052462}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P22223-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P22223-2; Sequence=VSP_024820;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in some normal epithelial tissues
CC       and in some carcinoma cell lines. {ECO:0000269|PubMed:2702654}.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of
CC       each cadherin domain and rigidify the connections, imparting a
CC       strong curvature to the full-length ectodomain. {ECO:0000250}.
CC   -!- DISEASE: Hypotrichosis congenital with juvenile macular dystrophy
CC       (HJMD) [MIM:601553]: A disorder characterized by congenital
CC       hypotrichosis, early hair loss, and severe degenerative changes of
CC       the retinal macula that culminate in blindness during the second
CC       to third decade of life. {ECO:0000269|PubMed:11544476,
CC       ECO:0000269|PubMed:12445216}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ectodermal dysplasia, ectrodactyly, and macular dystrophy
CC       syndrome (EEMS) [MIM:225280]: A form of ectodermal dysplasia, a
CC       heterogeneous group of disorders due to abnormal development of
CC       two or more ectodermal structures. It is an autosomal recessive
CC       condition characterized by features of ectodermal dysplasia such
CC       as sparse eyebrows and scalp hair, and selective tooth agenesis
CC       associated with macular dystrophy and ectrodactyly.
CC       {ECO:0000269|PubMed:15805154}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Contains 5 cadherin domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00043}.
CC   -!- WEB RESOURCE: Name=Mutations of the CDH3 gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/cdh3mut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X63629; CAA45177.1; -; mRNA.
DR   EMBL; AK312554; BAG35451.1; -; mRNA.
DR   EMBL; CH471092; EAW83238.1; -; Genomic_DNA.
DR   EMBL; BC014462; AAH14462.1; -; mRNA.
DR   EMBL; BC041846; AAH41846.1; -; mRNA.
DR   EMBL; X95824; CAA65093.1; -; Genomic_DNA.
DR   CCDS; CCDS10868.1; -. [P22223-1]
DR   PIR; A33659; IJHUCP.
DR   RefSeq; NP_001784.2; NM_001793.4. [P22223-1]
DR   UniGene; Hs.191842; -.
DR   PDB; 4OY9; X-ray; 1.62 A; A=108-320.
DR   PDBsum; 4OY9; -.
DR   ProteinModelPortal; P22223; -.
DR   SMR; P22223; 108-647, 729-822.
DR   BioGrid; 107436; 7.
DR   IntAct; P22223; 5.
DR   STRING; 9606.ENSP00000264012; -.
DR   PhosphoSite; P22223; -.
DR   BioMuta; CDH3; -.
DR   DMDM; 146345382; -.
DR   MaxQB; P22223; -.
DR   PaxDb; P22223; -.
DR   PRIDE; P22223; -.
DR   DNASU; 1001; -.
DR   Ensembl; ENST00000264012; ENSP00000264012; ENSG00000062038.
DR   Ensembl; ENST00000429102; ENSP00000398485; ENSG00000062038. [P22223-2]
DR   GeneID; 1001; -.
DR   KEGG; hsa:1001; -.
DR   UCSC; uc002ewf.2; human. [P22223-1]
DR   CTD; 1001; -.
DR   GeneCards; GC16P068679; -.
DR   H-InvDB; HIX0026973; -.
DR   HGNC; HGNC:1762; CDH3.
DR   HPA; CAB002487; -.
DR   HPA; HPA001767; -.
DR   MIM; 114021; gene.
DR   MIM; 225280; phenotype.
DR   MIM; 601553; phenotype.
DR   neXtProt; NX_P22223; -.
DR   Orphanet; 1897; EEM syndrome.
DR   Orphanet; 1573; Hypotrichosis with juvenile macular degeneration.
DR   PharmGKB; PA26299; -.
DR   eggNOG; NOG328838; -.
DR   GeneTree; ENSGT00760000118906; -.
DR   HOGENOM; HOG000231254; -.
DR   HOVERGEN; HBG106438; -.
DR   InParanoid; P22223; -.
DR   KO; K06796; -.
DR   OMA; AGWLAMD; -.
DR   OrthoDB; EOG7PS1DS; -.
DR   PhylomeDB; P22223; -.
DR   TreeFam; TF316817; -.
DR   Reactome; REACT_19195; Adherens junctions interactions.
DR   ChiTaRS; CDH3; human.
DR   GeneWiki; CDH3_(gene); -.
DR   GenomeRNAi; 1001; -.
DR   NextBio; 4208; -.
DR   PRO; PR:P22223; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; P22223; -.
DR   CleanEx; HS_CDH3; -.
DR   ExpressionAtlas; P22223; baseline and differential.
DR   Genevisible; P22223; HS.
DR   GO; GO:0005913; C:cell-cell adherens junction; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0034332; P:adherens junction organization; TAS:Reactome.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0034329; P:cell junction assembly; TAS:Reactome.
DR   GO; GO:0045216; P:cell-cell junction organization; TAS:Reactome.
DR   GO; GO:0022405; P:hair cycle process; IMP:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0031424; P:keratinization; IMP:UniProtKB.
DR   GO; GO:0051796; P:negative regulation of catagen; IMP:UniProtKB.
DR   GO; GO:0032912; P:negative regulation of transforming growth factor beta2 production; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0043568; P:positive regulation of insulin-like growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0010838; P:positive regulation of keratinocyte proliferation; IMP:UniProtKB.
DR   GO; GO:0048023; P:positive regulation of melanin biosynthetic process; IMP:UniProtKB.
DR   GO; GO:1902910; P:positive regulation of melanosome transport; IMP:UniProtKB.
DR   GO; GO:0032773; P:positive regulation of monophenol monooxygenase activity; IMP:UniProtKB.
DR   GO; GO:0060901; P:regulation of hair cycle by canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0001895; P:retina homeostasis; IMP:UniProtKB.
DR   GO; GO:0016337; P:single organismal cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   Gene3D; 2.60.40.60; -; 5.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom.
DR   Pfam; PF00028; Cadherin; 4.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 4.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 3.
DR   PROSITE; PS50268; CADHERIN_2; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cell membrane; Cleavage on pair of basic residues; Complete proteome;
KW   Disease mutation; Ectodermal dysplasia; Glycoprotein; Hypotrichosis;
KW   Membrane; Metal-binding; Polymorphism; Reference proteome; Repeat;
KW   Sensory transduction; Signal; Transmembrane; Transmembrane helix;
KW   Vision.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   PROPEP       25    107
FT                                /FTId=PRO_0000003745.
FT   CHAIN       108    829       Cadherin-3.
FT                                /FTId=PRO_0000003746.
FT   TOPO_DOM    108    654       Extracellular. {ECO:0000255}.
FT   TRANSMEM    655    677       Helical. {ECO:0000255}.
FT   TOPO_DOM    678    829       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      108    215       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      216    328       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      329    440       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      441    546       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      547    650       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   COMPBIAS    785    800       Ser-rich.
FT   CARBOHYD    200    200       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    566    566       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     761    829       NLKAANTDPTAPPYDTLLVFDYEGSGSDAASLSSLTSSASD
FT                                QDQDYDYLNEWGSRFKKLADMYGGGEDD -> GRGERGSQR
FT                                GNGGLQLARGRTRRS (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_024820.
FT   VARIANT     237    237       V -> M (in dbSNP:rs17854171).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031929.
FT   VARIANT     322    322       N -> I (in EEMS).
FT                                {ECO:0000269|PubMed:15805154}.
FT                                /FTId=VAR_033010.
FT   VARIANT     477    477       R -> H (in dbSNP:rs34494880).
FT                                /FTId=VAR_031930.
FT   VARIANT     503    503       R -> H (in HJMD).
FT                                {ECO:0000269|PubMed:12445216}.
FT                                /FTId=VAR_015422.
FT   VARIANT     563    563       Q -> H (in dbSNP:rs1126933).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15805154,
FT                                ECO:0000269|PubMed:2793940,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_031931.
FT   STRAND      114    119       {ECO:0000244|PDB:4OY9}.
FT   STRAND      124    130       {ECO:0000244|PDB:4OY9}.
FT   HELIX       134    137       {ECO:0000244|PDB:4OY9}.
FT   STRAND      141    148       {ECO:0000244|PDB:4OY9}.
FT   TURN        149    151       {ECO:0000244|PDB:4OY9}.
FT   STRAND      152    154       {ECO:0000244|PDB:4OY9}.
FT   STRAND      157    160       {ECO:0000244|PDB:4OY9}.
FT   TURN        162    164       {ECO:0000244|PDB:4OY9}.
FT   STRAND      166    169       {ECO:0000244|PDB:4OY9}.
FT   TURN        175    177       {ECO:0000244|PDB:4OY9}.
FT   STRAND      179    189       {ECO:0000244|PDB:4OY9}.
FT   STRAND      199    206       {ECO:0000244|PDB:4OY9}.
FT   STRAND      214    216       {ECO:0000244|PDB:4OY9}.
FT   STRAND      218    225       {ECO:0000244|PDB:4OY9}.
FT   STRAND      233    236       {ECO:0000244|PDB:4OY9}.
FT   STRAND      246    249       {ECO:0000244|PDB:4OY9}.
FT   STRAND      254    262       {ECO:0000244|PDB:4OY9}.
FT   STRAND      270    272       {ECO:0000244|PDB:4OY9}.
FT   TURN        274    276       {ECO:0000244|PDB:4OY9}.
FT   STRAND      278    281       {ECO:0000244|PDB:4OY9}.
FT   TURN        288    290       {ECO:0000244|PDB:4OY9}.
FT   STRAND      293    301       {ECO:0000244|PDB:4OY9}.
FT   HELIX       303    305       {ECO:0000244|PDB:4OY9}.
FT   STRAND      309    319       {ECO:0000244|PDB:4OY9}.
SQ   SEQUENCE   829 AA;  91418 MW;  7C03C8536CD98C7B CRC64;
     MGLPRGPLAS LLLLQVCWLQ CAASEPCRAV FREAEVTLEA GGAEQEPGQA LGKVFMGCPG
     QEPALFSTDN DDFTVRNGET VQERRSLKER NPLKIFPSKR ILRRHKRDWV VAPISVPENG
     KGPFPQRLNQ LKSNKDRDTK IFYSITGPGA DSPPEGVFAV EKETGWLLLN KPLDREEIAK
     YELFGHAVSE NGASVEDPMN ISIIVTDQND HKPKFTQDTF RGSVLEGVLP GTSVMQVTAT
     DEDDAIYTYN GVVAYSIHSQ EPKDPHDLMF TIHRSTGTIS VISSGLDREK VPEYTLTIQA
     TDMDGDGSTT TAVAVVEILD ANDNAPMFDP QKYEAHVPEN AVGHEVQRLT VTDLDAPNSP
     AWRATYLIMG GDDGDHFTIT THPESNQGIL TTRKGLDFEA KNQHTLYVEV TNEAPFVLKL
     PTSTATIVVH VEDVNEAPVF VPPSKVVEVQ EGIPTGEPVC VYTAEDPDKE NQKISYRILR
     DPAGWLAMDP DSGQVTAVGT LDREDEQFVR NNIYEVMVLA MDNGSPPTTG TGTLLLTLID
     VNDHGPVPEP RQITICNQSP VRQVLNITDK DLSPHTSPFQ AQLTDDSDIY WTAEVNEEGD
     TVVLSLKKFL KQDTYDVHLS LSDHGNKEQL TVIRATVCDC HGHVETCPGP WKGGFILPVL
     GAVLALLFLL LVLLLLVRKK RKIKEPLLLP EDDTRDNVFY YGEEGGGEED QDYDITQLHR
     GLEARPEVVL RNDVAPTIIP TPMYRPRPAN PDEIGNFIIE NLKAANTDPT APPYDTLLVF
     DYEGSGSDAA SLSSLTSSAS DQDQDYDYLN EWGSRFKKLA DMYGGGEDD
//
